Moteur de recherche d’entreprises européennes
Financement de l’UE (3 911 897 €) : Mécanismes biochimiques et mécanochimiques dans les cellules polarisées Hor01/01/2015 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Mécanismes biochimiques et mécanochimiques dans les cellules polarisées
BIOPOL is an interdisciplinary European training network at the interface of cell biology, physics and engineering. BIOPOL aims specifically at the understanding of fundamental mechanochemical principles guiding cellular behaviour and function and their relevance to human disease. A new supra-disciplinary research field is emerging bringing together the fields of molecular cell biology, physics and engineering aiming at an in depth understanding of fundamental cellular mechanochemical principles. BIOPOL combines exactly this required expertise in one joint training program for young researchers. BIOPOL has assembled a unique multidisciplinary consortium bringing together top scientists from the fields of molecular/developmental cell biology, membrane physics, engineering as well as specialists from the private sector. The scientific objectives focus on understanding of fundamental mechanisms of cellular mechanosensing in health and disease, the role of external forces in cell division and mechanochemical regulation of cell polarity including tissue formation. Finally, part of BIOPOL´s research program is the further development of cutting edge technologies like advanced atomic force microscopy, novel photonic tools like optical stretcher or innovative organ on a chip technology, exploiting physical cellular properties. BIOPOL´s collaborative cutting edge research program is integral part of its training program provided to early stage researcher and is further translated into seven state of the art experimental training stations representing the consortiums expertise. In addition, BIOPOL has developed a 3 years modular curriculum including workshops, summerschools, Business plan competitions and conferences with a specific agenda of transferable skill training elements highly relevant for scientific communication, translational research and in particular entrepreneurship.
| Andor Technology Ltd. | ? |
| Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) | 495 746 € |
| Highlight Therapeutics SL | 0,00 € |
| Institut Curie | 788 627 € |
| JPK Instruments AG | 249 216 € |
| Mimetas B.V. | 255 374 € |
| Technische Universitaet Dresden | 498 433 € |
| The Chancellor Masters and Scholars of the University of Cambridge | 273 288 € |
| The University of Sheffield | 819 864 € |
| Universita Degli Studi Di Padova | 258 061 € |
| University College London | 273 288 € |
https://cordis.europa.eu/project/id/641639
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Andor Technology Ltd., Belfast, Royaume Uni.